Company to host a webcasttoday at 8:30 a.m. Eastern TimeNEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the ...
An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.
Researchers discovered that raising the protein Sox9 can help the brain's astrocytes clear out toxic plaque buildup linked to ...
The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a ...
Rutgers neuroscientist Peng Jiang and his neuroscience colleague Mengmeng Jin have made a discovery they say could reshape ...
Rutgers neuroscientist Peng Jiang was visiting his hometown of Qianshan, a city in China's Anhui province, when a neighbor ...
Morning Overview on MSN
A simple molecule reversed Alzheimer’s signs in rats
In a series of recent animal studies, a handful of deceptively simple molecules have done something that once sounded like ...
Researchers discovered that raising the protein Sox9 can help the brain’s astrocytes clear out toxic plaque buildup linked to ...
Researchers identify neurotoxic protein complex and a pharmacological inhibitor that opens new perspectives for developing ...
For more information about brain health, please see recent studies that oral cannabis extract may help reduce Alzheimer’s ...
One possible option is lithium, a mineral that is best known as a treatment for bipolar disorder. Lithium has shown promise ...
Scientists have developed a new molecule that breaks down beta-amyloid plaques by binding to excess copper in the brain. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results